<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37282564</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1778-3585</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>European psychiatry : the journal of the Association of European Psychiatrists</Title><ISOAbbreviation>Eur Psychiatry</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizens.</ArticleTitle><Pagination><StartPage>e50</StartPage><MedlinePgn>e50</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e50</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1192/j.eurpsy.2023.2418</ELocationID><Abstract><AbstractText Label="BACKGROUND">Current evidence on the risk of admission- or medication-requiring psychiatric sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is limited to selected populations, short durations, and loss to follow-up. This study examined if SARS-CoV-2 infection was associated with increased long-term risk of psychiatric admissions and <i>de novo</i> prescription of psychoactive medication in the general population of Denmark.</AbstractText><AbstractText Label="METHODS">Adults (&#x2265;18 years) were assigned to either the control or SARS-CoV-2 group based on polymerase chain reaction (PCR) tests between 1 January 2020 and 27 November 2021. Infected subjects were matched 1:5 to control subjects by propensity score. Incidence rate ratios (IRRs) were calculated. Adjusted Cox regression was applied to the unmatched population with SARS-CoV-2 infection as a time-dependent covariate. Follow-up time was 12 months or until the end of the study.</AbstractText><AbstractText Label="RESULTS">A total of 4,585,083 adults were included in the study. Approximately 342,084 had a PCR-confirmed SARS-CoV-2 infection and were matched 1:5 with 1,697,680 controls. The IRR for psychiatric admission was 0.79 in the matched population (95% confidence interval [CI]: 0.73-0.85, <i>p</i> &lt; 0.001). In the unmatched population, the adjusted hazard ratios (aHR) for psychiatric admission were either below 1.00 or with a 95% CI lower limit of 1.01. SARS-CoV-2 infection was associated with an increased risk of <i>de novo</i> prescription of psychoactive medication in both the matched (IRR 1.06, 95% CI: 1.02-1.11, <i>p</i> &lt; 0.01) and unmatched population (HR 1.31, 95% CI: 1.28-1.34, <i>p</i> &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSIONS">We found a signal of increased use of psychoactive medication, specifically benzodiazepines, among SARS-CoV-2-positive persons, but the risk of psychiatric admissions did not increase.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>R&#xf8;mer</LastName><ForeName>Valdemar</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-1814-7639</Identifier><AffiliationInfo><Affiliation>Section of Respiratory Medicine, Herlev-Gentofte University Hospital, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivapalan</LastName><ForeName>Pradeesh</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8620-3655</Identifier><AffiliationInfo><Affiliation>Section of Respiratory Medicine, Herlev-Gentofte University Hospital, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ekl&#xf6;f</LastName><ForeName>Josefin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3739-7526</Identifier><AffiliationInfo><Affiliation>Section of Respiratory Medicine, Herlev-Gentofte University Hospital, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Susanne D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0001-6391-7455</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases, University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harboe</LastName><ForeName>Zitta B</ForeName><Initials>ZB</Initials><Identifier Source="ORCID">0000-0001-5552-0095</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary and Infectious Diseases, University Hospital of Copenhagen, North Zealand, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biering-S&#xf8;rensen</LastName><ForeName>Tor</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4209-2778</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itenov</LastName><ForeName>Theis</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1204-3636</Identifier><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Jens-Ulrik S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0003-4036-0521</Identifier><AffiliationInfo><Affiliation>Section of Respiratory Medicine, Herlev-Gentofte University Hospital, Hellerup, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Psychiatry</MedlineTA><NlmUniqueID>9111820</NlmUniqueID><ISSNLinking>0924-9338</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006778" MajorTopicYN="N">Hospitals, Psychiatric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="N">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">psychiatry</Keyword><Keyword MajorTopicYN="N">psychopharmaceuticals</Keyword></KeywordList><CoiStatement>The authors declare none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37282564</ArticleId><ArticleId IdType="pmc">PMC10305760</ArticleId><ArticleId IdType="doi">10.1192/j.eurpsy.2023.2418</ArticleId><ArticleId IdType="pii">S0924933823024185</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Altmann DM, Boyton RJ. Decoding the unknowns in long covid. BMJ. 2021;372:n132. doi:10.1136/bmj.n132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n132</ArticleId><ArticleId IdType="pubmed">33541867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;5. doi:10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini AM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID: a systematic review. Int J Clin Pract. 2021;75:e14357. doi:10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi:10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, Barzegary A, et al. Late complications of COVID-19; a systematic review of current evidence. Arch Acad Emerg Med. 2021;9(1):e14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7927752</ArticleId><ArticleId IdType="pubmed">33681819</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130&#x2013;40. doi:10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875&#x2013;82. doi:10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalleballe K, Reddy Onteddu S, Sharma R, Dandu V, Brown A, Jasti M, et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun. 2020;88:71&#x2013;4. doi:10.1016/j.bbi.2020.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.020</ArticleId><ArticleId IdType="pmc">PMC7297688</ArticleId><ArticleId IdType="pubmed">32561222</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;27. doi:10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162. doi:10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55&#x2013;8. doi:10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy D, Ghosh R, Dubey S, Dubey MJ, Benito-Leon J, Kanti Ray B. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021;48(1):9&#x2013;24. doi:https://doi.org/10.1017/cjn.2020.173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.173</ArticleId><ArticleId IdType="pmc">PMC7533477</ArticleId><ArticleId IdType="pubmed">32753076</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88(1):1&#x2013;11. doi:10.1002/ana.25807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25807</ArticleId><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. J Alzheimers Dis. 2020;76(1):3&#x2013;19. doi:10.3233/JAD-200581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200581</ArticleId><ArticleId IdType="pmc">PMC7660990</ArticleId><ArticleId IdType="pubmed">32538857</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, et al. The neurology of COVID-19 revisited: a proposal from the environmental neurology specialty Group of the World Federation of neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. doi:10.1016/j.jns.2020.116884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116884</ArticleId><ArticleId IdType="pmc">PMC7204734</ArticleId><ArticleId IdType="pubmed">32464367</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia AO, Feitosa PWG, Moreira JLS, Nogueira SAR, Fonseca RB, Nobre MEP. Neurological manifestations of COVID-19 and other coronaviruses: a systematic review. Neurol Psychiatry Brain Res. 2020;37:27&#x2013;32. doi:10.1016/j.npbr.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.npbr.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7261450</ArticleId><ArticleId IdType="pubmed">32834527</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldi M, Pignataro G, Taglialatela M. Neurobiology of coronaviruses: potential relevance for COVID-19. Neurobiol Dis. 2020;143:105007. doi:10.1016/j.nbd.2020.105007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105007</ArticleId><ArticleId IdType="pmc">PMC7329662</ArticleId><ArticleId IdType="pubmed">32622086</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, et al. Onset and frequency of depression in post-COVID-19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129&#x2013;37. doi:10.1016/j.jpsychires.2021.09.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwu CJ, Iwu CD, Wiysonge CS. The occurrence of long COVID: a rapid review. Pan Afr Med J. 2021;38:65. doi:10.11604/pamj.2021.38.65.27366.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.65.27366</ArticleId><ArticleId IdType="pmc">PMC8028365</ArticleId><ArticleId IdType="pubmed">33889231</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes EA, O&#x2019;Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547&#x2013;60. doi:10.1016/S2215-0366(20)30168-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30168-1</ArticleId><ArticleId IdType="pmc">PMC7159850</ArticleId><ArticleId IdType="pubmed">32304649</ArticleId></ArticleIdList></Reference><Reference><Citation>Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. 2020;89:531&#x2013;42. doi:10.1016/j.bbi.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7260522</ArticleId><ArticleId IdType="pubmed">32485289</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7 Suppl):22&#x2013;5. doi:10.1177/1403494810387965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1403494810387965</ArticleId><ArticleId IdType="pubmed">21775345</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449&#x2013;90. doi:10.2147/CLEP.S91125.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S91125</ArticleId><ArticleId IdType="pmc">PMC4655913</ArticleId><ArticleId IdType="pubmed">26604824</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannesdottir SA, Horvath-Puho E, Ehrenstein V, Schmidt M, Pedersen L, Sorensen HT. Existing data sources for clinical epidemiology: The Danish National Database of reimbursed prescriptions. Clin Epidemiol. 2012;4:303&#x2013;13. doi:10.2147/CLEP.S37587.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37587</ArticleId><ArticleId IdType="pmc">PMC3508607</ArticleId><ArticleId IdType="pubmed">23204870</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonning K, Dessau RB, Jensen TG, Thorsen NM, Wiuff C, Nielsen L, et al. Electronic reporting of diagnostic laboratory test results from all healthcare sectors is a cornerstone of national preparedness and control of COVID-19 in Denmark. APMIS 2021;129(7):438&#x2013;51. doi:10.1111/apm.13140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.13140</ArticleId><ArticleId IdType="pmc">PMC8239934</ArticleId><ArticleId IdType="pubmed">33949007</ArticleId></ArticleIdList></Reference><Reference><Citation>Grove Krause T, Jakobsen S, Haarh M, Molbak K. The Danish vaccination register. Euro Surveill. 2012;17(17):20155. doi:10.2807/ese.17.17.20155-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.17.17.20155-en</ArticleId><ArticleId IdType="pubmed">22551494</ArticleId></ArticleIdList></Reference><Reference><Citation>(SSI) SSI. Tidslinje for covid-19, https://covid19.ssi.dk/-/media/arkiv/subsites/covid19/presse/tidslinje-over-covid-19/covid-19-tidslinje-for-2020-2022-lang-version---version-1---april-2022.pdf; 2022.  [accessed 21 September 2022].</Citation></Reference><Reference><Citation>Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson comorbidity index: ICD-9 update and ICD-10 translation. Am Health Drug Benefits. 2019;12(4):188&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684052</ArticleId><ArticleId IdType="pubmed">31428236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho D, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1&#x2013;28. doi:10.18637/jss.v042.i08.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v042.i08</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouder JN, Engelhardt CR, McCabe S, Morey RD. Model comparison in ANOVA. Psychon Bull Rev. 2016;23(6):1779&#x2013;86. doi:10.3758/s13423-016-1026-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/s13423-016-1026-5</ArticleId><ArticleId IdType="pubmed">27068543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Liu Y, Tang X, He D. The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern. Front Public Health. 2021;9:775224. doi:10.3389/fpubh.2021.775224.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.775224</ArticleId><ArticleId IdType="pmc">PMC8669511</ArticleId><ArticleId IdType="pubmed">34917580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Sampalo A, Bernal-Lopez MR, Gomez-Huelgas R, Persistent COVID-19 syndrome. A narrative review. Rev Clin Esp (Barc). 2022;222(4):241&#x2013;50. doi:10.1016/j.rceng.2021.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rceng.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8882405</ArticleId><ArticleId IdType="pubmed">35260380</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-acute sequelae of SARS-CoV-2 infection among adults aged &gt;/=18 years - long beach, California, April 1&#x2013;December 10, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(37):1274&#x2013;7. doi:10.15585/mmwr.mm7037a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigod SN, Kurdyak P, Fung K, Gruneir A, Herrmann N, Hussain-Shamsy N, et al. Psychiatric hospitalizations: a comparison by gender, sociodemographics, clinical profile, and postdischarge outcomes. Psychiatr Serv. 2016;67(12):1376&#x2013;9. doi:10.1176/appi.ps.201500547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ps.201500547</ArticleId><ArticleId IdType="pubmed">27476808</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukamoto R, Kataoka Y, Mino K, Ishibashi N, Shibata M, Matsuo H, et al. Gender differences in anxiety among COVID-19 inpatients under isolation: a questionnaire survey during the first and second waves of the COVID-19 pandemic in Japan. Front Public Health. 2021;9:708965. doi:10.3389/fpubh.2021.708965.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.708965</ArticleId><ArticleId IdType="pmc">PMC8563575</ArticleId><ArticleId IdType="pubmed">34746076</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154&#x2013;62. doi:10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, et al. COVID-19 vaccination for the prevention and treatment of long COVID: a systematic review and meta-analysis. Brain Behav Immun. 2023;111: 211&#x2013;29. doi:10.1016/j.bbi.2023.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>(Sundhedsstyrelsen) DHA. National klinisk retningslinje for behandling af angstlidelser hos voksne, https://www.sst.dk/-/media/Udgivelser/2021/NKR_Angstlidelser/Endelig-rapport---NKR-for-behandling-af-angslidelser-hos-voksne.ashx; 2021.  [accessed 21 September 2022].</Citation></Reference><Reference><Citation>Cloos JM, Ferreira V. Current use of benzodiazepines in anxiety disorders. Curr Opin Psychiatry. 2009;22(1):90&#x2013;5. doi:10.1097/YCO.0b013e32831a473d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/YCO.0b013e32831a473d</ArticleId><ArticleId IdType="pubmed">19122540</ArticleId></ArticleIdList></Reference><Reference><Citation>Romer TB, Christensen RHB, Blomberg SN, Folke F, Christensen HC, Benros ME. Psychiatric admissions, referrals, and suicidal behavior before and during the COVID-19 pandemic in Denmark: a time-trend study. Acta Psychiatr Scand. 2021;144(6):553&#x2013;62. doi:10.1111/acps.13369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acps.13369</ArticleId><ArticleId IdType="pmc">PMC8652698</ArticleId><ArticleId IdType="pubmed">34525216</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022;376:e068993. doi:10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - a systematic review. Brain Behav Immun. 2021;97:328&#x2013;48. doi:10.1016/j.bbi.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, Lainez-Ramos-Bossini AJ, de Alba IG, Ortiz-Gonzalez-Serna R, Serrano-Ortiz A, Fernandez-Martinez NF, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med. 2022;20(1):92. doi:10.1186/s12916-022-02292-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02292-6</ArticleId><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts HA, Clark DA, Kalina C, Sherman C, Brislin S, Heitzeg MM, et al. To vax or not to vax: predictors of anti-vax attitudes and COVID-19 vaccine hesitancy prior to widespread vaccine availability. PLoS One. 2022;17(2):e0264019. doi:10.1371/journal.pone.0264019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264019</ArticleId><ArticleId IdType="pmc">PMC8846500</ArticleId><ArticleId IdType="pubmed">35167612</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson SF, Laursen TM, Osler M, Hjorthoj C, Benros ME, Ethelberg S, et al. Vaccination against SARS-CoV-2 infection among vulnerable and marginalised population groups in Denmark: a nationwide population-based study. Lancet Reg Health Eur. 2022;16:100355. doi:10.1016/j.lanepe.2022.100355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100355</ArticleId><ArticleId IdType="pmc">PMC8948003</ArticleId><ArticleId IdType="pubmed">35350631</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson SF, Laursen TM, Osler M, Hjorthoj C, Benros ME, Ethelberg S, et al. Adverse SARS-CoV-2-associated outcomes among people experiencing social marginalisation and psychiatric vulnerability: a population-based cohort study among 4,4 million people. Lancet Reg Health Eur. 2022;20:100421. doi:10.1016/j.lanepe.2022.100421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100421</ArticleId><ArticleId IdType="pmc">PMC9242846</ArticleId><ArticleId IdType="pubmed">35789954</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>